Introduction
Coumarin-induced skin necrosis is an uncommon complication of oral anticoagulation, seen typically during induction of therapy. It has been described in association with venous thrombosis due to inherited deficiency of protein C (PC).' PC is a vitamin K-dependent serine protease with an anticoagulant activity directed against clotting factors V and VIII. Protein S (PS), another naturally occuring vitamin K-dependent anticoagulant, acts as a cofactor for PC. PS deficiency has also been described in association with a familial venous thrombotic tendency. Recently, coumarin-induced skin necrosis has been described in association with PS. 2 We describe a kindred with PS deficiency in which the proposita suffered skin necrosis at the onset of treatment with oral anticoagulants.
Case report
The patient, a young woman, presented in 1985 at the age of 21 with a history of pleuritic chest pain and a painful swollen left leg. She had been on the oral contraceptive pill for 3 years and was a cigarette smoker. She had had an uneventful pregnancy in 1980-81. A diagnosis of left iliac vein thrombosis and pulmonary embolus was made on clinical grounds; treatment was started with intravenous heparin (40,000 units/24 hours) and a loading dose (6 mg) of nicoumalone was given. She received a total of 12 mg of nicoumalone in divided doses over the first 72 hours.
At the end of this period, when the British Ratio (BR) had risen to 4.9, the patient began to complain of a burning sensation in the left thigh. An area ofdiscolouration developed on the thigh, with bruising and blistering on the skin, followed by an extensive area of skin necrosis ( Figure 1 ). The dose of nicoumalone was reduced to maintain the BR at -2.0. The necrotic area became infected and a further admission was required for desloughing and skin grafting. Long term anticoagulation was maintained with nicoumalone. In March 1986 the patient became pregnant again: subcutaneous heparin was substituted for nicoumalone during the last trimester. However, she developed a further pulmonary embolus, and required admission for treatment with full dose intravenous heparin. She subsequently delivered a healthy infant, and there were no haemorrhagic complications. Following delivery, long term anticoagulation with nicoumalone was successfully recommenced.
Investigation demonstrated PS deficiency in the proposita, her mother and one of her two brothers (Table I ). The patient's mother is asymptomatic, but the brother has had several episodes of deep venous thrombosis. He is anticoagulated with warfarin and has had no episodes of skin necrosis. The diagnosis ofcongenital PS deficiency is difficult in patients receiving oral anticoagulants. In patients stabilized on oral anticoagulants comparison can be made between PS and Factor II levels as both are normally depressed to a similar level. The disproportionately low PS level in the first brother is highly suggestive of congenital PS deficiency. The second brother is asymptomatic and has normal PS levels.
Functional PC was measured using a chromogenic method. The relative changes in the vitamin K-dependent factors are less marked if anticoagulation is initiated using smaller, divided doses of a longacting coumarin drug.6 If skin necrosis should occur during induction of anticoagulation, it is generally recommended that heparin be reintroduced and oral anticoagulants reduced to a minimum.
As far as we are aware, formal recommendations have not been made for the management of congenital PS deficiency in pregnancy. Carriers of the defect are at increased risk of thromboembolism particularly during the last trimester and postpartum period, and surveillance should be especially vigilant at these times. 'Vigorous short term prophylaxis' has been recommended in general terms (though not specifically for pregnancy)'0 but, as indicated by the course of events in our patient, carriers with a past history of venous thromboembolism may not be protected by currently recommended antenatal anticoagulant regimes. However, we are reluctant to recommend heparin throughout pregnancy because of the dangers of osteopenia. and skin necrosis. 
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